Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, October 23, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accelerate Scientific Breakthroughs
Life Sciences Times
-
August 10, 2021
0
Venture Capital
Visus Therapeutics Secures $20 Million in Additional Financing Led by New Investor LSP, with Participation from Sage Partners
Life Sciences Times
-
August 10, 2021
0
Venture Capital
Sydnexis Secures $45 Million Series B Financing Led by Visionary Ventures and Blue Stem Capital
Life Sciences Times
-
August 10, 2021
0
Venture Capital
Lucid Lane Raises $16 Million Series A From Accel and Battery Ventures to Help People Living with Medication Dependence
Life Sciences Times
-
August 9, 2021
0
Venture Capital
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III
Life Sciences Times
-
August 9, 2021
0
Venture Capital
EQRx to Accelerate Growth with $1.8 Billion Raise through Proposed Combination with CM Life Sciences III
Life Sciences Times
-
August 6, 2021
0
Venture Capital
As Industrial Automation Market Explodes, Third Wave Automation Closes $40M Series B
Life Sciences Times
-
August 5, 2021
0
Venture Capital
Veranex Announces Acquisition of Experien Group
Life Sciences Times
-
August 5, 2021
0
Venture Capital
Encellin Closes $5.9M Seed Financing Co-Led by Khosla Ventures and SV Latam Capital
Life Sciences Times
-
August 5, 2021
0
Venture Capital
Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing
Life Sciences Times
-
August 4, 2021
0
Venture Capital
Tsingyuan Ventures Rebrands to Foothill Ventures, Closes Oversubscribed $100M Fund
Life Sciences Times
-
August 4, 2021
0
Venture Capital
Clarify Health Acquires Apervita’s Value Optimization Business, Creating One Unified Value Platform for Health Plans
Life Sciences Times
-
August 4, 2021
0
1
...
103
104
105
...
115
Page 104 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026